Qymune Advances to Second Phase of Research Collaboration with Daiichi Sankyo
Qymune Selected for the Memorial Sloan Kettering Cancer Center Therapeutics Accelerator 2026 Cohort
Qymune Announces Research Collaboration with Daiichi Sankyo to Advance Next-Generation T Cell Engager Technology
